Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Trial Holdings, Ordinary Profit Forecast for the Fiscal Year Revised Upward by 24%
141A Trial Holdings Inc. 【J-GAAP】
Earnings ReportTrial Holdings Inc. <141A> [TSE Growth] announced its financial results after the market closed on May 14th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending June 2026 (July 2025 to March 2026) expanded 20.0 billion yen, an increase 38.6% compared to the same period last year.
In addition, the full-year forecast for consolidated ordinary profit has been revised upward 24.5%, from the previous forecast of 13.9 billion yen to 17.3 billion yen (compared to 22.2 billion yen in the previous period), and the declining rate is expected to decrease from 37.4% to 22.1%.
Based on the full-year plan announced by the company after the upward revision, our estimate of the consolidated ordinary profit for the January to June period (second half) has been revised upward from an expected loss of 0.56 billion yen to a profit of 2.83 billion yen (compared to a profit of 11.5 billion yen in the same period of the previous year), turning to a profit.
In the most recent three-month period, from January to March (3Q), the consolidated ordinary profit increased 45.5% from the same period last year, reaching 5.63 billion yen. However, the operating profit margin remained almost flat, changing from 1.9% in the same period last year to 1.9%.
Kabutan News
Actual Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jul - Mar, 2023 | 537,217 | 15,397 | 16,167 | 9,494 | 96.7 | 81.7 | May 14, 2024 | J-GAAP |
| Jul - Mar, 2024 | 600,037 | 13,464 | 14,493 | 8,374 | 68.6 | 65.3 | May 14, 2025 | J-GAAP |
| Jul - Mar, 2025 | 1,003,663 | 22,943 | 20,093 | 5,922 | 48.4 | 116.1 | May 14, 2026 | J-GAAP |
| YoY | +67.3% | +70.4% | +38.6% | -29.3% | -29.5% |
Guidance Update
Second Half Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2026 Prev | 648,383 | 8,723 | -562 | -3,557 | -29.0 | 16 | Feb 12, 2026 | J-GAAP |
| Jan - Jun, 2026 New | 668,383 | 11,323 | 2,838 | -3,557 | -29.0 | 16 | May 14, 2026 | J-GAAP |
| Revision Rate | +3.1% | +29.8% | - | 0.0% | 0.0% |
Full Year Update
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2026 Prev | 1,322,500 | 25,400 | 13,900 | 500 | 4.1 | 16 | Aug 13, 2025 | J-GAAP |
| Jun, 2026 New | 1,342,500 | 28,000 | 17,300 | 500 | 4.1 | 16 | May 14, 2026 | J-GAAP |
| Revision Rate | +1.5% | +10.2% | +24.5% | 0.0% | 0.0% |
Current Period Guidance
Second Half Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Jun, 2025 | 400,088 | 11,406 | 11,576 | 5,620 | 46.0 | 16 | Aug 13, 2025 | J-GAAP |
| Jan - Jun, 2026 Guidance | 668,383 | 11,323 | 2,838 | -3,557 | -29.0 | 16 | May 14, 2026 | J-GAAP |
| YoY | +67.1% | -0.7% | -75.5% | - | - |
Current Period Guidance
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jun, 2024 | 717,948 | 19,161 | 19,789 | 11,439 | 109.8 | 15 | Aug 13, 2024 | J-GAAP |
| Jun, 2025 | 803,829 | 21,106 | 22,200 | 11,752 | 96.2 | 16 | Aug 13, 2025 | J-GAAP |
| Jun, 2026 Guidance | 1,342,500 | 28,000 | 17,300 | 500 | 4.1 | 16 | May 14, 2026 | J-GAAP |
| YoY | +67.0% | +32.7% | -22.1% | -95.7% | -95.8% |
Quarterly Results
| Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
|---|---|---|---|---|---|---|---|---|
| Jan - Mar, 2025 | 196,296 | 3,764 | 3,869 | 2,242 | 18.4 | 1.9 | May 14, 2025 | J-GAAP |
| Apr - Jun, 2025 | 203,792 | 7,642 | 7,707 | 3,378 | 27.7 | 3.7 | Aug 13, 2025 | J-GAAP |
| Jul - Sep, 2025 | 326,617 | 5,140 | 3,247 | -979 | -8.0 | 1.6 | Nov 13, 2025 | J-GAAP |
| Oct - Dec, 2025 | 347,500 | 11,537 | 11,215 | 5,036 | 41.2 | 3.3 | Feb 12, 2026 | J-GAAP |
| Jan - Mar, 2026 | 329,546 | 6,266 | 5,631 | 1,865 | 15.2 | 1.9 | May 14, 2026 | J-GAAP |
| YoY | +67.9% | +66.5% | +45.5% | -16.8% | -17.0% |
Related Articles
WILL GROUP, 5% Decrease in Net Income for The Current Fiscal Year
PRONEXUS, 5% Decrease in Net Income for The Current Fiscal Year, Increased Previous Year's Dividend by 4 Yen, This Fiscal Year to Increase Dividend by 2 Yen
Kurita Water Industries, 2.6 times Increase in Net Income, Record High for The First Time in Three Years, Dividend Raised by 22 Yen
AnyMind Group, Jan-Mar (1Q) Net Income Increases by 5.1 times
KADOKAWA, 3% Increase in Ordinary Profit for The Current Fiscal Year
VALTES HOLDINGS, 3% Increase in Ordinary Profit for The Current Fiscal Year
DLE, Returning to Profitability This Year
Noile-Immune Biotech, Jan-Mar (1Q) Ordinary Profit Loss Narrows
SYNCLAYER, Jan-Mar (1Q) Ordinary Profit Decreases by 26%
SERENDIP HOLDINGS, 36% Increase in Ordinary Profit, Update Record High for Fourth Consecutive Term